Repurposing existing drugs for COVID-19: an endocrinology perspective

by Flavio A. Cadegiani
Published 2020-09-01

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (AR...

by Flavio A. Cadegiani, Flavio A. Cadegiani, Carlos G. Wambier, Andy Goren, Andy Goren
Published 2020-07-01

Enhancement of hypothalamic-pituitary activity in male athletes: evidence of a novel hormonal mechanism of physical conditioning

by Flavio A. Cadegiani, Claudio E. Kater
Published 2019-11-01

Eating, Sleep, and Social Patterns as Independent Predictors of Clinical, Metabolic, and Biochemical Behaviors Among Elite Male Athletes: The EROS-PREDICTORS Study

by Flavio A. Cadegiani, Claudio E. Kater
Published 2020-06-01

Novel causes and consequences of overtraining syndrome: the EROS-DISRUPTORS study

by Flavio A. Cadegiani, Claudio E. Kater
Published 2019-09-01

Inter-correlations Among Clinical, Metabolic, and Biochemical Parameters and Their Predictive Value in Healthy and Overtrained Male Athletes: The EROS-CORRELATIONS Study

by Flavio A. Cadegiani, Claudio E. Kater
Published 2019-12-01

Hormonal aspects of overtraining syndrome: a systematic review

by Flavio A. Cadegiani, Claudio E. Kater
Published 2017-08-01

Hypothalamic-Pituitary-Adrenal (HPA) Axis Functioning in Overtraining Syndrome: Findings from Endocrine and Metabolic Responses on Overtraining Syndrome (EROS)—EROS-HPA Axis

by Flavio A. Cadegiani, Claudio E. Kater
Published 2017-12-01

Novel insights of overtraining syndrome discovered from the EROS study

by Flavio A Cadegiani, Claudio Elias Kater
Published 2019-10-01